Inhibition of PDGF-BB reduces alkali-induced corneal neovascularization in mice

Lei Chen1, Hongya Wu2, Chi Ren1

  • 1Department of Ophthalmology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China.

Insights

Platelet-derived growth factor (PDGF)-BB/PDGF receptor (R)-β signaling promotes corneal neovascularization by enhancing endothelial cell activity. Inhibiting this pathway reduces new blood vessel growth in the cornea.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Cell Biology

Background:

  • Corneal neovascularization (CrNV) is a significant cause of vision impairment.
  • The molecular mechanisms driving CrNV, particularly the role of growth factors, require further elucidation.

Purpose of the Study:

  • To investigate the role of platelet-derived growth factor (PDGF)-BB/PDGF receptor (R)-β signaling in an experimental murine corneal neovascularization (CrNV) model.
  • To determine the effects of PDGF-BB on endothelial cell functions in vitro.

Main Methods:

  • Corneal neovascularization was induced by alkali injury in mice.
  • Immunohistochemistry and immunofluorescence staining were used to assess protein expression.
  • Reverse transcription-quantitative PCR (RT-qPCR) evaluated gene expression in human retinal endothelial cells (HRECs).
  • In vitro assays (Cell Counting Kit-8, wound healing, 3D Matrigel assay) assessed HREC proliferation, migration, and tube formation.

Main Results:

  • PDGF-BB and PDGFR-β expression increased in the cornea post-injury.
  • Neutralizing anti-PDGF-BB antibody significantly inhibited CrNV.
  • PDGF-BB/PDGFR-β signaling promoted HREC proliferation, migration, and tube formation, especially under hypoxic conditions.
  • Inhibition of PDGF-BB signaling altered the expression of pro- and anti-angiogenic factors.

Conclusions:

  • PDGF-BB/PDGFR-β signaling plays a crucial role in promoting corneal neovascularization.
  • This pathway enhances endothelial cell proliferation, migration, and tube formation.
  • Targeting PDGF-BB/PDGFR-β signaling may offer a therapeutic strategy for managing CrNV.

Related Concept Videos